Trials / Not Yet Recruiting
Not Yet RecruitingNCT07473232
Comparison of Platelet-rich Plasma and Activated Cytokine-rich Serum Injection Treatments in Patients With Knee Osteoarthritis. (KOA PRP ACS)
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Pamukkale University · Academic / Other
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The effects of single dose injection of platelet rich plasma or conditioned serum in the knee joint in patients with knee osteoarthritis will be compared
Detailed description
Patients with early grade bilateral knee osteoarthritis (Kellgren Lawrence grade 1 or 2) will be divided into 2 groups. One group of patients will be injected with single dose of autologous platelet rich plasma (PRP) in the knee joints. Other group of patients will be injected with eqiuvolume of autologous conditioned serum (CS) (also known as activated cytokine rich serum) in the knee joints. Patients' serum before injection, the treatment product (PRP and CS), patients serum 30 min after injection will be investigated for IL-1β, IL-1Ra, PDGF-BB, IGF-1, TGF-β and TNF-α. Patients' serum 1 week and 1 month after injection will be investigated for MMP-13, COMP by ELISA. Patients will also be investigated for visual pain scale, WOMAC (Western Ontorino and Mc Master) scale range of motion, ultrasonographic tibiofemoral cartilage thickness measurement and functional tests including the 30-second chair test, stair climb test, 40 meter fast paced walk test, timed up and go test, 6-minute walk test, and walking speed in the first week, first month and third month after injection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Autologous Platelet-Rich Plasma (PRP) | Autologous Platelet-Rich Plasma (PRP) will be injected intra-articularly in patients with knee osteoarthritis |
| DRUG | Conditioned serum (CS) | Autologous conditionedserum (CS) will be injected intra-articularly in patients with knee osteoarthritis |
Timeline
- Start date
- 2026-04-01
- Primary completion
- 2026-06-30
- Completion
- 2026-06-30
- First posted
- 2026-03-16
- Last updated
- 2026-03-19
Source: ClinicalTrials.gov record NCT07473232. Inclusion in this directory is not an endorsement.